92 related articles for article (PubMed ID: 23060560)
1. Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogs.
Helson L; Bolger G; Majeed M; Vcelar B; Pucaj K; Matabudul D
Anticancer Res; 2012 Oct; 32(10):4365-70. PubMed ID: 23060560
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs.
Matabudul D; Pucaj K; Bolger G; Vcelar B; Majeed M; Helson L
Anticancer Res; 2012 Oct; 32(10):4359-64. PubMed ID: 23060559
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Greil-Ressler S; Weiss L; Schönlieb C; Magnes T; Radl B; Majeed M; Sordillo PP
Cancer Chemother Pharmacol; 2019 Feb; 83(2):265-275. PubMed ID: 30430227
[TBL] [Abstract][Full Text] [Related]
4. Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Majeed M; Helson L
Anticancer Res; 2017 Jul; 37(7):3483-3492. PubMed ID: 28668837
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger GT; Licollari A; Tan A; Greil R; Pleyer L; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2018 Jan; 38(1):121-130. PubMed ID: 29277764
[No Abstract] [Full Text] [Related]
7. Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
Bolger GT; Licollari A; Bagshaw R; Tan A; Greil R; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2019 Mar; 39(3):1161-1168. PubMed ID: 30842145
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of curcumin through reduction and glucuronidation in mice.
Pan MH; Huang TM; Lin JK
Drug Metab Dispos; 1999 Apr; 27(4):486-94. PubMed ID: 10101144
[TBL] [Abstract][Full Text] [Related]
9. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats.
Murugan P; Pari L
J Ethnopharmacol; 2007 Sep; 113(3):479-86. PubMed ID: 17693046
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
Chism JP; Rickert DE
Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
[TBL] [Abstract][Full Text] [Related]
11. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs.
Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S
Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697
[TBL] [Abstract][Full Text] [Related]
12. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
13. Clearance studies of methotrexate in dogs after multiple-rate infusion.
Lui CY; Lee MG; Chiou WL
Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
[TBL] [Abstract][Full Text] [Related]
14. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats.
Pari L; Murugan P
Ren Fail; 2007; 29(7):881-9. PubMed ID: 17994458
[TBL] [Abstract][Full Text] [Related]
15. A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome.
Li J; Jiang Y; Wen J; Fan G; Wu Y; Zhang C
Biomed Chromatogr; 2009 Nov; 23(11):1201-7. PubMed ID: 19488971
[TBL] [Abstract][Full Text] [Related]
16. Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs.
D'Amour P; Rousseau L; Rocheleau B; Pomier-Layrargues G; Huet PM
J Bone Miner Res; 1996 Aug; 11(8):1075-85. PubMed ID: 8854243
[TBL] [Abstract][Full Text] [Related]
17. Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats.
Murugan P; Pari L
Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):241-5. PubMed ID: 17845505
[TBL] [Abstract][Full Text] [Related]
18. Clearance and tissue uptake following 4-hour and 24-hour infusions of pamidronate in rats.
Pongchaidecha M; Daley-Yates PT
Drug Metab Dispos; 1993; 21(1):100-4. PubMed ID: 8095201
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
